ClinicalTrials.gg
CompletedNCT01752283Updated Dec 19, 2012

Video-assisted Thyroid Surgery and Hypnosis in Thyroid Surgery

An interventional study of video-assisted thyroidectomy and Video-assisted thyroidectomy in Surgery, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Completed at 1 site in Belgium. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2012-12-19.

Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Non-randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The study is aimed to investigate the safety and feasibility of Video-assisted thyroidectomy under hypnosis in comparison to general anesthesia

Read the detailed description

Summary of the project

video-assisted thyroidectomy (MIVAT): General anesthesia (GA) versus hypnosis (HY)

Investigators

Prof. Michel Mourad*, Dr. Christine Watremez **, Prof. Fabienne Roelants**

* Surgery and Abdominal Transplantation Division

** Department of Anesthesiology,

Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium

  1. Aim

    The aim of this pilot study is to prospectively investigate, in a consecutive series of patients, the feasibility and safety of MIVAT under HY associated with local anesthesia, compared to GA.

  2. Inclusion criteria

    • Adult patients candidates to total or partial thyroidectomy.
    • ASA 1, 2 or 3
    • One surgeon (MM)
    • Informed consent
  3. Exclusion criteria

    • Age \<18 years
    • The presence of familial medullary thyroid cancers
    • Suspicious or metastatic lymph nodes
    • Redo surgery
    • ASA 4 patients
    • Patients with chronic pain
    • Deaf people
    • Patients with psychiatric diseases
    • Known recurrent nerve paralysis
  4. Outcome evaluation

    • Primary outcomes: safety and feasibility.
    • During surgery, considered events for analysis should include operating time (from skin incision to skin closure), total time in the operating room, intraoperative bleeding, drug consumption, Hemodynamic changes and conversion rates from MIVAT to a conventional approach and from HY to GA.
    • After surgery, comparative variables for analysis should include: drug consumption, hospital stay, calcemia, and vocal cord abnormality on the basis of day-one laryngoscopy performed by an ENT doctor not involved in the study.
  5. Patients selection and study groups:

Selection of patients for MIVAT is based on the size of the gland and nodules, provided that the craniocaudal axis of the lobes did not exceed 7cm and the largest transversal diameter was less than 3.5cm. All patients who are assigned to undergo MIVAT are instructed about the possibility of conversion to a conventional approach. The patients are left free to choose the type of anesthesia they prefere for their surgical intervention. They have to give informed consent before the procedure.

A. General anesthesia group:

Premedication:

  • Lorazepam 0.5 mg 1 h before surgery
  • ECG, NIBP, SaO2
  • VVP + NaCl 0.9 % 500 mL + taradyl 0.5 mg / kg (\<30 mg)

Induction:

  • Remifentanil 0.05 µg/kg/min
  • Propofol 2 mg/kg
  • Intubation with an armored endotracheal tube specially devised for neuromonitoring of the vocal cords.

During surgery:

  • Sevoflurane / Remifentanil

B. Hypnosis group:

Premedication:

  • Lorazepam 0.5 mg 1 h avant l'intervention
  • ECG, NIBP, SaO2
  • VVP + NaCl 0.9 % 500 mL + taradyl 0.5 mg / kg (\< 30 mg)

Induction and during surgery:

  • Remifentanil modified as requested
  • Induction of hypnosis according to Milton Eriksson technique
  • Midazolam (titrated 0.1 mg/0.1mg) if needed as anxiolytic.
  • Local anesthesia mixture (lidocaine 0.5%/ropivacaine 0.25%) to be administered by the surgeon along the incision line 5 minutes before making the skin incision.
02

Conditions studied

  • Surgery

Keywords

  • Videoassited
  • Thyroidectomy
  • Minimal invasive surgery
  • General anesthesia
  • Hypnosis
03

In context

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the lead sponsor of 348 studies on the registry; 62 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The selection of patients for MIVAT was achieved according to the size of the gland and nodules provided that the cranio-caudal axis of the lobes does not exceed 7 centimeters and the largest transversal diameter is less than 3.5 centimeters
  • Age >18 years

Exclusion criteria

Exclusion Criteria:

  • No previous neck surgery
  • No known malignancy
  • No history of neck irradiation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
130 participants (actual)

Study arms

  • Experimental
    Hypnosis and local anesthesia

    video-assisted thyroidectomy under hypnosis and local anesthesia.

    Procedure: video-assisted thyroidectomy

  • Active comparator
    General anesthesia

    Video-assisted thyroidectomy under general anesthesia

    Procedure: video-assisted thyroidectomy

Interventions

  • Procedurevideo-assisted thyroidectomy

    Experimental arm: video-assisted thyroidectomy under local anesthesia and hypnosis

  • ProcedureVideo-assisted thyroidectomy

    video-assisted thyroidectomy under general anesthesia

06

What researchers measure

Primary outcomes

  1. Feasibility

    To assess technical feasibility

    Time frame: Intraoperative

Secondary outcomes

  1. Operating time

    Time frame: during surgery

  2. Intraoperative bleeding

    Time frame: During surgery

  3. Conversion to general anesthesia

    Time frame: During surgery

  4. Conversion from video-assisted technique to conventional surgery

    Time frame: During surgery

Other outcomes

  1. Hemodynamic changes

    Time frame: During surgery

  2. Drug consumption

    Time frame: During surgery and up to 6 hours after surgery

07

Study locations

1 site
  • Cliniques Universitaires Saint-Luc. 10 Avenue Hippocrate
    Brussels, 1200, Belgium
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2010, a primary completion of Dec 2011 and a completion of Jun 2012. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 31, 2012
First posted
Dec 19, 2012
Start
Jan 2010
Primary completionActual
Dec 2011
CompletionActual
Jun 2012
Last update
Dec 19, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 19, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01752283
Responsible party
Mourad (MD, PhD, Cliniques universitaires Saint-Luc- Université Catholique de Louvain) — Principal investigator
First posted
Dec 19, 2012
Start date
Jan 2010
Primary completion
Dec 2011
Completion
Jun 2012
Last update
Dec 19, 2012

Study contacts

Michel Mourad, MD, PhD
principal investigator · Cliniques Universitaires Saint-Luc. 10 Avenue Hippocrate, 10. 1200 Bruxelles

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion